Tiantan Bio
600161.SS
#3640
Rank
โ‚น368.67 B
Marketcap
โ‚น186.45
Share price
-2.86%
Change (1 day)
-18.47%
Change (1 year)

Revenue for Tiantan Bio (600161.SS)

Revenue in 2026 (TTM): โ‚น74.30 Billion

According to Tiantan Bio's latest financial reports the company's current revenue (TTM ) is โ‚น80.36 Billion. In 2024 the company made a revenue of โ‚น71.72 Billion an increase over the revenue in the year 2023 that were of โ‚น60.85 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Tiantan Bio from 2002 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น74.30 B
2024 โ‚น71.72 B17.86%
2023 โ‚น60.85 B17.21%
2022 โ‚น51.91 B9.34%
2021 โ‚น47.48 B29.02%
2020 โ‚น36.80 B9.11%
2019 โ‚น33.72 B10.2%
2018 โ‚น30.60 B59.25%
2017 โ‚น19.21 B-9.55%
2016 โ‚น21.24 B24.4%
2015 โ‚น17.08 B-8.81%
2014 โ‚น18.72 B1.05%
2013 โ‚น18.53 B41.71%
2012 โ‚น13.07 B13.52%
2011 โ‚น11.52 B43.58%
2010 โ‚น8.02 B-10.23%
2009 โ‚น8.93 B86.84%
2008 โ‚น4.78 B72.27%
2007 โ‚น2.77 B19.8%
2006 โ‚น2.31 B22.74%
2005 โ‚น1.88 B24.29%
2004 โ‚น1.51 B12.68%
2003 โ‚น1.34 B16.54%
2002 โ‚น1.15 B